(Q48361641)
Statements
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials (English)
M Rovaris
R Capra
T A Yousry
M P Sormani
F Prandini
V Martinelli
I Kühne
C Pozzilli